Quarterly ResultMay 6, 2026, 04:14 PM
LifeVantage Q3 Revenue Down 25.2% to $43.7M; EPS $0.11; Dividend +11.1%
AI Summary
LifeVantage Corporation reported a significant decline in its third fiscal quarter 2026 results, with revenue decreasing by 25.2% to $43.7 million and diluted EPS falling to $0.11 from $0.26 year-over-year. The decline was primarily attributed to lower sales of the MindBody GLP-1 System, partially offset by the LoveBiome acquisition. Despite the top-line headwinds, the company increased its quarterly cash dividend by 11.1% to $0.05 per share and continued share repurchases, while also adjusting its fiscal year 2026 guidance to the lower end of previous expectations.
Key Highlights
- Revenue decreased 25.2% to $43.7 million in Q3 fiscal 2026 from $58.4 million in prior year.
- Net income per diluted share was $0.11, down from $0.26 a year ago.
- Adjusted EBITDA was $3.2 million, compared to $6.4 million in the prior year period.
- Americas revenue decreased 28.9%, while Asia/Pacific & Europe revenue decreased 7.7%.
- The company declared a cash dividend of $0.05 per common share, an 11.1% increase.
- Approximately 250,000 common shares were repurchased for $1.6 million in the first nine months.
- Fiscal year 2026 revenue, adjusted EBITDA, and adjusted EPS are expected near the lower end of guidance.
Price Impact
More from LFVN